What Medicare Plans Cover Spiriva (Tiotropium)
Medicare Part D prescription drug plans typically cover Spiriva (tiotropium) [1][2]. The specific formulary and tier placement of Spiriva can vary by plan, which affects the out-of-pocket cost [2]. Patients should verify coverage and costs with their individual Medicare Part D plan provider [2]. Medicare Advantage plans that include prescription drug coverage (MAPD plans) also generally cover Spiriva [1].
How to Find Medicare Coverage for COPD Medications
To determine Medicare coverage for Spiriva or other respiratory medications for COPD, individuals can use the Medicare Plan Finder tool on Medicare.gov. This tool allows users to compare different Part D and MAPD plans based on prescription drug formularies, costs, and provider networks [1]. Checking a specific plan's formulary is essential to confirm if Spiriva is included and at what cost [2].
What are Alternatives to Spiriva Covered by Medicare?
Several alternative bronchodilator medications for COPD may be covered by Medicare Part D plans, depending on the specific formulary. These alternatives often include other long-acting muscarinic antagonists (LAMAs) and long-acting beta-agonists (LABAs) [3][4]. Examples of commonly covered alternatives include [3][4]:
* Umeclidinium (e.g., Incruse Ellipta)
* Glycopyrrolate (often in combination inhalers)
* Salmeterol
* Formoterol
It is crucial for patients to consult their doctor to discuss alternative treatment options and then verify Medicare coverage for any recommended medication through their plan's formulary or the Medicare Plan Finder [1][2].
What is the Difference Between Spiriva and Other Bronchodilators?
Spiriva (tiotropium) is a long-acting muscarinic antagonist (LAMA) that works by relaxing the muscles in the airways, making it easier to breathe [3]. It is prescribed for the long-term management of bronchospasm associated with COPD, including emphysema and chronic bronchitis [5]. Other bronchodilators include short-acting beta-agonists (SABAs), long-acting beta-agonists (LABAs), and other LAMAs. The choice of medication often depends on the severity of COPD, individual patient response, and the presence of other conditions [3][4]. For instance, LABAs are also bronchodilators but work on a different receptor in the airways. Combination inhalers that contain both a LAMA and a LABA are also available and may be prescribed for patients requiring more advanced treatment [4].
When Does the Patent for Spiriva Expire?
The primary patents for Spiriva have expired, allowing for the availability of generic versions of tiotropium [6]. DrugPatentWatch.com tracks patent expirations and the introduction of generics for various medications [7]. The expiration of patents generally leads to the availability of lower-cost generic alternatives.
---
Sources
1. https://www.medicare.gov/
2. https://www.medicare.gov/drug-coverage-part-d
3. https://www.ncbi.nlm.nih.gov/books/NBK537265/
4. https://www.lung.org/lung-health-and-diseases/lung-disease-lookup/copd/treatment-and-prevention/medications
5. https://www.boehringer-ingelheim.us/patient-care/diseases-and-conditions/respiratory/copd/spiriva
6. https://www.accessdata.fda.gov/scripts/cder/ob/default.cfm
7. https://drugpatentwatch.com/